期刊文献+

Biological Evaluation and Structure Modification of (S)-3-Aminopyrrolidine Derivatives 被引量:1

Biological Evaluation and Structure Modification of (S)-3-Aminopyrrolidine Derivatives
原文传递
导出
摘要 With our interest in (S)-3-aminopyrrolidine derivatives,we further screened inhibition activities of three hit compounds on many other kinases with the results demonstrating that this series of compounds shows better anticancer activities,which might result from the main block of PI3K/Akt signaling pathway and the inhibition of Abelson murine leukemia viral oncogene homolog(ABL) kinase,as well as some epidermal growth factors.Further structure modification demonstrates that benzylsulfonyl group is the necessary functional group contributing to the biological activity that will be helpful to guiding us to optimize these (S)-3-aminopyrrolidine derivatives. With our interest in (S)-3-aminopyrrolidine derivatives,we further screened inhibition activities of three hit compounds on many other kinases with the results demonstrating that this series of compounds shows better anticancer activities,which might result from the main block of PI3K/Akt signaling pathway and the inhibition of Abelson murine leukemia viral oncogene homolog(ABL) kinase,as well as some epidermal growth factors.Further structure modification demonstrates that benzylsulfonyl group is the necessary functional group contributing to the biological activity that will be helpful to guiding us to optimize these (S)-3-aminopyrrolidine derivatives.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2014年第1期91-97,共7页 高等学校化学研究(英文版)
关键词 (S)-3-Aminopyrrolidine Biological evaluation Structure modification (S)-3-Aminopyrrolidine Biological evaluation Structure modification
  • 相关文献

参考文献20

  • 1Druker B.J;Talpaz M;Resta D.J;Peng B;Buchdunger E;Ford J.M;Lydon N.B;Kantarjian H;Capdeville R;Ohno-Jones S;Sawyers C.L.查看详情[J],New England Journal of Medicine20011031.
  • 2Liao J.J.L.查看详情[J],Journal of Medicinal Chemistry2007409.
  • 3Morphy R.查看详情[J],Journal of Medicinal Chemistry20101413.
  • 4Golas J.M;Arndt K;Etienne C;Lucas J;Nardin D;Gibbons J;Frost P;Ye F;Boschelli D.H;Boschelli F.查看详情[J],CANCER RESEARCH2003375.
  • 5Kimura S;Naito H;Segawa H;Kuroda J;Yuasa T;Sato K;Yokota A;Kamitsuji Y;Kawata E;Ashihara E;Nakaya Y;Naruoka H;Wakayama T;Nasu K;Asaki T;Niwa T;Hirabayashi K;Maekawa T.查看详情[J]Blood,20053948.
  • 6Lockton J.A;Smethurst D;Macpherson M;Tootell R;Marshall A.L;Clack G;Gallagher N.J.查看详情[J],Journal of Clinical Oncology2005223s.
  • 7Daub H;Specht K;Ullrich A.查看详情[J],Nat Rev Drug Discovery20041001.
  • 8Shah N.P;Nicoll J.M;Nagar B;Gorre M.E;Paquette R.L;Kuriyan J;Sawyers C.L.查看详情[J],CANCER CELLS2002117.
  • 9Weisberg E;Griffin J.D.查看详情[J],Drug Resist Updates200122.
  • 10Weisberg E;Griffin J.D.查看详情[J]Blood,20003498.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部